Scotland · NHS Scotland MSAN
NovoRapid® PumpCart® (insulin aspart) 100units/ml solution for injection 1.6ml
MSAN(2025)27 · Level 2 · issued 06 Jun 2025
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| cartridges are in limited supply until 2027 and cannot support new patient initiations. | Limited supply | 2027 |
| 2. Alternative insulin aspart products including NovoRapid® vials remain available and can | Available | — |
| remains available and can support increased demand. | Available | — |
| 11. Please note: Trurapi® vials remain available but cannot currently support any increase in | Available | — |
| you need to register with the SPS website. Registration for access to the website is available to | Available | — |
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.